SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

Sun Pharmaceutical Industries Ltd.

NSE: SUNPHARMA | BSE: 524715 | ISIN: INE044A01036 | Industry: Pharmaceuticals
| Mid-range Performer

1716.1000 18.30 (1.08%)

NSE Nov 11, 2025 15:51 PM

Volume: 1.3M

Conference/Earnings Calls Alerts

Sun Pharmaceutical Industries Ltd.

03 Aug 2022

1716.10

1.08%

Earnings Call

SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Transcript of the Company's Q1FY23 earnings conference call.

More from Sun Pharmaceutical Industries Ltd.

Recommended

Market closes higher, Bajaj Finance's Q2 net profit grows 22% YoY

Trendlyne Marketwatch | 11 Nov 2025, 04:03PM

IPO market heats up: Physicswallah and six others to open, five listings this week

| 10 Nov 2025, 05:36PM

Change is hard, and some Indian pharma companies are embracing it better than others